Venus Concept Inc logo

VERO - Venus Concept Inc News Story

$1.48 -0.1  -3.9%

Last Trade - 26/01/22

Small Cap
Market Cap £61.8m
Enterprise Value £108.3m
Revenue £73.2m
Position in Universe 5577th / 7412

Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Tue 7th September, 2021 9:05pm
For best results when printing this announcement, please click on link below:

TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus
Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic
technology leader, today announced that management will participate in the
H.C. Wainwright 23rd Annual Global Investment Conference, which is being held
virtually from September 13th-15th. Management’s presentation will be
available on-demand beginning on Monday, September 13th at 7:00 a.m. Eastern
Time. Management will participate in virtual investor meetings on Tuesday,
September 14th throughout the day.

An audio webcast of the presentation will be accessible under the “Events”
section of the Company's investor relations website at An archive of the webcast will be available for
replay following the conference.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with
a broad product portfolio of minimally invasive and non-invasive medical
aesthetic and hair restoration technologies and reach in over 60 countries and
20 direct markets. Venus Concept focuses its product sales strategy on a
subscription-based business model in North America and in its well-established
direct global markets. Venus Concept’s product portfolio consists of
aesthetic device platforms, including Venus Versa, Venus Legacy, Venus
Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss,
Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems
includes NeoGraft®, an automated hair restoration system that facilitates the
harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX®
Robotic Hair Restoration systems, which harvest follicular units directly from
the scalp and create recipient implant sites using proprietary algorithms.
Venus Concept has been backed by leading healthcare industry growth equity
investors including EW Healthcare Partners (formerly Essex Woodlands),
HealthQuest Capital, Longitude Capital Management, and Aperture Venture

Investor Relations Contact:

Westwicke on behalf of Venus Concept:

Mike Piccinino, CFA


GlobeNewswire, Inc. 2021
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.